Cargando…
Efficacy of biological response modifier lentinan with chemotherapy for advanced cancer: a meta‐analysis
Lentinan is a common biological response modifier. This study was sought to evaluate the efficacy of adjuvant lentinan combined with chemotherapy for advanced cancer. A meta‐analysis of published prospective controlled trials investigating the effects of lentinan for kinds of advanced cancer was per...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633561/ https://www.ncbi.nlm.nih.gov/pubmed/28940986 http://dx.doi.org/10.1002/cam4.1156 |